title: Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014.
authors.forename: Allen D
authors.initials: AD
authors.lastname: Seftel
mesh_terms: D026683:Advisory Committees; D000728:Androgens / Q000627:therapeutic use*; D003226:Congresses as Topic; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000592:standards*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D012308:Risk Management; D013739:Testosterone / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000728:Androgens; D013739:Testosterone